RT @ASBMR: Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy is Associated with Decreased Fractures in Women with Breast Cancer #JBMR https://t.co/3ry2KlI0Jy https://t.co/Q7wllDYA09
Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy is Associated with Decreased Fractures in Women with Breast Cancer #JBMR https://t.co/3ry2KlI0Jy pic.twitter.com/Q7wllDYA09
— ASBMR (@ASBMR) February 4, 2021
from Twitter https://twitter.com/GastonR48222321
February 04, 2021 at 02:51PM
Comentarios
Publicar un comentario